| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 517.12 Million | USD 941.04 Million | 6.17% | 2024 |
FrequentlyAsked Questions
As per U.S. FDA, automated endoscope reprocessors are key medical instruments that finds key applications in healthcare surroundings for reprocessing endoscopes such as duodenoscopes and endoscope accessories. Reportedly, these medical devices are designed for killing microorganisms present on or within reusable endoscopes by exposing them to high proportion of disinfectants or sterilant solutions.
The global automated endoscope reprocessors market is expected to grow due to increasing number of endoscopic procedures, rising concerns about hospital-acquired infections (HAIs) and patient safety, and growing technological advancements in reprocessing equipment.
According to a study, the global automated endoscope reprocessors market size was worth around USD 517.12 Million in 2024 and is expected to reach USD 941.04 Million by 2034.
The global automated endoscope reprocessors market is expected to grow at a CAGR of 6.17% during the forecast period.
North America is expected to dominate the automated endoscope reprocessors market over the forecast period.
Leading players in the global automated endoscope reprocessors market include Custom Ultrasonics, Inc., STERIS Plc., Hoya Corporation, Olympus Corporation, Advanced Sterilization Products Services Inc, Laboratory Anios, Getinge AB, Metull Zug AG, Steelco S.p.A., Cantel Medical Corp., Johnson & Johnson, among others.
The report explores crucial aspects of the automated endoscope reprocessors market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients